ASC-69
PD-1/PD-L1-IN-29 intermediate-2
Sasanlimab
Pimivalimab
Pucotenlimab
Erfonrilimab
Retifanlimab
Rosnilimab
Rulonilimab
Cosibelimab
Zeluvalimab
Sudubrilimab
Reozalimab
Emfizatamab
Peresolimab
Lodapolimab
Prolgolimab
Opucolimab
Camrelizumab
Pacmilimab